Top Markets
#1 Akedo Akedo +69.97%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.06%
#4 Cross Cross +36.90%
#5 Velvet Velvet +31.95%
#6 Black Phoenix Black Phoenix +26.64%
#7 Cap Cap +22.61%
#8 OVERTAKE OVERTAKE +19.97%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.79%
#10 Ontology Gas Ontology Gas +11.65%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
H-CYTE, Inc. H-CYTE, Inc.

H-CYTE, Inc.

HCYT
Rank in Stocks #39159
H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated... H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated to developing and supplying a range of treatments for individuals afflicted with persistent respiratory and pulmonary diseases. The company's core strategy involves pioneering and deploying autologous cellular therapy solutions specifically for chronic lung conditions. Additionally, H-CYTE maintains a product supply agreement with Rion, LLC, focused on advancing and distributing a biologic compound designed to combat chronic obstructive pulmonary disease (COPD). Its corporate headquarters are situated in Tampa, Florida.
Share Price
$0.995
Last synced: 2023-07-07
Market Cap
$624.98K
Change (1 day)
-0.50%
Change (1 year)
0.00%
Country
US
Trade H-CYTE, Inc. (HCYT)

Category

Healthcare
Stock price history for H-CYTE, Inc. (HCYT)
Highest end of day price: $1.00 on 2023-07-01

Lowest end of day price: $5.94K on 2014-12-01
Stock price history of H-CYTE, Inc. from 2014 to 2026
Annual Stock Price Performance
Year Performance
2023 -80.40%
2022 -87.00%
2021 141.36%
2020 -87.14%
2019 -62.16%
2018 -47.41%
2017 -55.36%
2016 21.43%
2015 -80.31%
2014 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $504.83 29.34%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $839.07 28.61%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $728.83 6.71%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $252.06 11.35%
BE